CD34 and acute myeloid leukemia: After combining the percentage of CD34+ALDH+ at diagnosis with MRD, patients were regrouped, and CD34+ALDH+‐H/MRD‐H status was an independent adverse prognostic factor for relapse in t(8;21) AML.